AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT06161441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Carboplatin
Description: Administered IV Q3W
Study NCT06161441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cisplatin
Description: Administered IV Q3W
Study NCT06161441 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo
Description: Administered IV Q3W
Study NCT04837196 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intravenous (IV)
Study NCT05305911 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: SGLT-2 inhibitors
Description: SGLT2 inhibitor once daily for six months
Study NCT06535919 — intervention group
Intervention type: BEHAVIORAL
Intervention: Treatment as Usual
Description: Individuals will receive residential level of care followed by treatment at their partial hospitalization program.
Study NCT05432297 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Preventive physical exercise
Description: Daily physical activity depending on daily condition
Study NCT05305911 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo once daily for six months
Study NCT05531201 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: collaboration general practitioner and physiotherapist
Description: training general practitioner and physiotherapist
Study NCT06355284 — intervention group
Intervention type: OTHER
Intervention: Functional MRI
Description: While in the MRI scanner, participants will complete several classic experimental tasks designed to capture brain activity related to core cognitive features of overcontrol that impact social functioning. Tasks include the Stop Signal Task (error monitoring), Delay Discounting Task (valuation, impulsivity), and Reversal Learning (cognitive flexibility).
Study NCT05064267 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: phlebotomy
Description: phlebotomy will be performed to obtain coagulation labs of interest. Specifically, in addition to standard clinical labs, the following will be drawn on study participants: thrombelastography with platelet mapping, antithrombin, DIC panel, factor VIII, vWF antigen, Protein C antigen and activity, Protein S antigen and activity, and ferritin.
Study NCT06501209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: 5A-5R-based counselling session
Description: The 5As (Ask, Advise, Assess, Assist, Arrange) summarize all the activities that a healthcare provider can do to help a tobacco user (both smoking within 3-5 minutes in a primary care setting. This model can guide you through the right process to talk to respondents who are ready to quit tobacco use and deliver advice.~The 5 R's - relevance, risks, rewards, roadblocks, and repetition - are the content areas that should be addressed in a motivational counseling intervention to help those who are not ready to quit.
Study NCT06501209 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Counseling through mobile phone call and text message
Description: Participants will get weekly a phone call and a text message
Study NCT06522386 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pirtobrutinib
Description: Given by mouth
Study NCT05500599 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Fentanyl Citrate
Description: Intravenous Formulation of Fentanyl Citrate and Midazolam Administered Orally for Premedication
Study NCT06522386 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rituximab
Description: Given by vein (IV)
Study NCT06522386 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Venetoclax
Description: Given by mouth
Study NCT05637671 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: oxybutynin ER
Description: One study group will receive 10 mg of oxybutynin ER orally once daily for 12 weeks.
Study NCT05637671 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Paroxetine CR
Description: the other group will receive 12.5 mg of paroxetine CR orally once daily for 12 weeks.
Study NCT05443360 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: DENSITY™ (Amorphous calcium carbonate, ACC)
Description: 1. Dosage form: tablet~2. Dose(s): 1000 mg /tablet, comprising 500 mg amorphous calcium carbonate per tablet (calcium element 200mg)~3. Dosing schedule: The usual dose for oral use is 2 ACC tablets (400 mg calcium element) twice daily given after breakfast and dinner.
Study NCT05443360 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Crystalized calcium carbonate (CCC)
Description: 1. Dosage form: tablet~2. Dose(s): 1000 mg /tablet, comprising 500 mg crystalized calcium carbonate per tablet (calcium element 200mg)~3. Dosing schedule: The usual dose for oral use is 2 CCC tablets (400 mg calcium element) twice daily given after breakfast and dinner.
Study NCT05437159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Learning of non-native phoneme combinations: 6 training sessions
Description: Each trial of the training sessions will follow a simple reaction time protocol in which a nonsense syllable containing novel consonant clusters (e.g., GDADK) is produced as quickly and accurately as possible after an auditory prompt presented via earphones. During each training session, the participant will practice producing a set of 8 stimuli (the Fully Learned stimuli). Each of the 8 Fully Learned stimuli will be produced 60 times over the 6 training sessions.
Study NCT05437159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Learning of non-native phoneme combinations: 1 training session
Description: Each trial of the training sessions will follow a simple reaction time protocol in which a nonsense syllable containing novel consonant clusters (e.g., GDADK) is produced as quickly and accurately as possible after an auditory prompt presented via earphones. During the training session, the participant will practice producing a set of 3 stimuli (the Fully Learned stimuli). Each of the 3 Fully Learned stimuli will be produced 60 times.
Study NCT05437159 — intervention group
Intervention type: BEHAVIORAL
Group type: SHAM_COMPARATOR
Intervention: Learning of non-native phoneme combinations: 1 training session
Description: Each trial of the training sessions will follow a simple reaction time protocol in which a nonsense syllable containing novel consonant clusters (e.g., GDADK) is produced as quickly and accurately as possible after an auditory prompt presented via earphones. During the training session, the participant will practice producing a set of 3 stimuli (the Fully Learned stimuli). Each of the 3 Fully Learned stimuli will be produced 60 times.
Study NCT05437159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Learning of novel multisyllabic nonwords
Description: Each trial of the training sessions (total of 6 training sessions over 2 days) will follow a simple reaction time protocol in which a nonword stimulus formed by 2 or 3 syllables that are legal in American English is presented auditorily to the participant, who then produces the stimulus as quickly and accurately as possible. During training, each participant will repeatedly produce 6 nonwords, with each nonword produced a total of 60 times over the 6 training sessions.
Study NCT05437159 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Anodal tDCS
Description: Continuous anodal tDCS is delivered to a speech processing area of the brain during a 19-minute speech training session. The tDCS stimulation will ramp up to its maximum value (2 milliamperes) in the minute prior to the training session and maintained at that level throughout the session.
Study NCT05437159 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham tDCS
Description: Sham tDCS stimulation is delivered to a speech processing area of the brain during a 19-minute speech training session. During the minute prior to training onset, the tDCS stimulator is ramped up to 2 milliamperes and then back down to 0.
Study NCT05437159 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Learning of non-native phoneme combinations: 8 training sessions
Description: Each trial of the training sessions will follow a simple reaction time protocol in which a nonsense syllable containing novel consonant clusters (e.g., GDADK) is produced as quickly and accurately as possible after an auditory prompt presented via earphones. During each training session, the participant will practice producing a set of 3 stimuli (the Fully Learned stimuli). Each of the 3 Fully Learned stimuli will be produced 120 times over the 8 training sessions.
Study NCT05080127 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: ACTIVE_COMPARATOR
Intervention: application of the allergenic food
Description: a small amount of the allergenic fresh food will be placed on the forearm using a patch test sticker for 15 minutes. the skin reaction will be measured.
Study NCT05080127 — intervention group
Intervention type: COMBINATION_PRODUCT
Group type: EXPERIMENTAL
Intervention: application of the allergenic food
Description: a small amount of the allergenic fresh food will be placed on the forearm using a patch test sticker for 15 minutes. the skin reaction will be measured.
Study NCT04920422 — intervention group
Intervention type: OTHER
Intervention: No intervention
Description: Retrospective analysis using database without any intervention assigned in the study.
Study NCT04322981 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Pharmacist-Led care
Description: Rapid testing in a community pharmacy, with rapid linkage to care and treatment that is pharmacist-led
Study NCT04322981 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care (Hepatology)
Description: Rapid testing in a community pharmacy, with standard of care referral to academic hepatology
Study NCT06377306 — intervention group
Intervention type: BEHAVIORAL
Intervention: Effect of training loads and sport performance level on health and sport performance
Description: Effect of training loads and sport performance level on health and sport performance
Study NCT05049369 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Polysomnography
Description: Polysomnography is performed one time overnight
Study NCT06510621 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Socket-Shield Technique
Description: A high-speed turbine was used to cut the tooth crown 1.5-2 mm from the buccal gingival margin. The tooth was then divided along the long axis, approximately 2 mm from the buccal side(Figure 1c, 1d). The palatal roots were removed using minimally invasive elevation and extraction forceps. Next, the buccal socket-shield was trimmed to approximately 4-6 mm in height (1 mm from the buccal gingival margin)\[18\], 3-4 mm in width, and 1-1.5 mm in thickness\[19,20\]. The trimming process required with clear visualization of the shield and calibration by periodontal probe. Finally, the socket-shield was removed by minimally invasive forceps when the adjacent tooth moved proximate to the shield during the process of closing orthodontic gap.
Study NCT05720091 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: ZX-7101A 80mg
Description: a drug to treatment influenza in Chinese adults
Study NCT04699877 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Gilteritinib
Description: Oral
Study NCT06230991 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: SIM05
Description: SIM05 contains a blend of food-grade Bifidobacterium and Lactobacillus strains plus prebiotics
Study NCT03984188 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Theophylline ER
Description: 200 mg extended release (ER) low-dose theophylline taken orally daily
Study NCT03984188 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo oral tablet
Description: Manufactured methylcellulose placebo tablet taken orally daily
Study NCT03984188 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Standard of Care Treatment
Description: Per World Health Organization (WHO) guidelines for management of Chronic Obstructive Pulmonary Disease (COPD) treatment
Study NCT03984188 — intervention group
Intervention type: OTHER
Group type: PLACEBO_COMPARATOR
Intervention: Standard of Care Treatment
Description: Per World Health Organization (WHO) guidelines for management of Chronic Obstructive Pulmonary Disease (COPD) treatment
Study NCT05998564 — intervention group
Intervention type: DEVICE
Intervention: Connecting patients to both non-invasive monitors to observe and compare the monitor's capabilities.
Description: All patients will be connected to the NOL monitor and the SCA monitor during general anesthesia.
Study NCT05670756 — intervention group
Intervention type: OTHER
Intervention: Survey
Description: Parents/guardians will complete a survey about when the medication allergy was identified and the exact symptomatology that resulted in determination of the allergy.
Study NCT05631665 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Survey results before and after laser treatment
Description: Determination of sexual activity rates as points with a questionnaire before and after laser treatment for patients with postmenopausal sexual function problems.
Study NCT06538012 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Tumor Infiltrating Lymphocytes (TIL)
Description: Tumor Infiltrating Lymphocytes (TIL) IV
Study NCT06538012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Cyclophosphamide
Description: Cyclophosphamide will be administered as an intravenous (IV) infusion for two days.
Study NCT06538012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Fludarabine
Description: Fludarabine will be administered as an intravenous (IV) infusion for five days.
Study NCT06538012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Interleukin-2
Description: After TIL infusion, IL-2 will be started as a bolus administration every eight hours, for a maximum of eight doses.
Study NCT06538012 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Description: Intravenous (IV) infusion
Study NCT06253104 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: BodyMetrix Body Composition Ultrasound
Description: We will use a BodyMetrix Pro A-mode ultrasound device (BodyMetrix Pro, Intelametrix Inc., Livermore, CA) which is a lay imaging tool designed specifically to assess body composition. Images will be taken at two sites; the lateral thigh and bicep on the dominant side if able to identify, or else on the right side. On each visit, five images will be taken at each site (the lateral thigh and bicep). Participants will be measured 2-3 days from initiation in study, then 7 days after, and then weekly from the first measurement until time of advanced therapy, discharge, or death. This measurement sequence will then be repeated following advanced therapy up until discharge or death. Each measurement session will last about 20-30 minutes. This will be performed by the PI or members of the study team who have been trained by the research coordinator.
Study NCT05722457 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: external focus task focus in addition to physiotherapy and rehabilitation exercises
Description: The first study on the external focus was made in 1998 by Wulf, Ho ¨ß, \& Prinz, (1998). Focusing on the inside of the body while performing a movement is called internal (internal focus), focusing on the outside of the body is called external (external focus). Previous studies have shown that external focus is substantially more effective than internal focus in the performance of a movement.
Study NCT05722457 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: internal focus task focus in addition to physiotherapy and rehabilitation exercises
Description: he first study on the external focus was made in 1998 by Wulf, Ho ¨ß, \& Prinz, (1998). Focusing on the inside of the body while performing a movement is called internal (internal focus), focusing on the outside of the body is called external (external focus). Previous studies have shown that external focus is substantially more effective than internal focus in the performance of a movement.
Study NCT05400863 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: avoid sugary and NNS drinks plus start Metformin
Description: Subjects will receive education and counseling to avoid all sweetened drinks (drink water only). Participants will be asked to consume minimum of 3 drinks/day
Study NCT05400863 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: avoid sugary drinks (allowed water and drinks sweetened with NNS) plus start Metformin
Description: Subjects will avoid drinks sweetened with sugar (can have diet drinks sweetened with NNS). Participants will be asked to consume minimum of 3 drinks/day
Study NCT05362305 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Essential Coaching for Every Mother
Description: Daily text messages for the first six-weeks postpartum.
Study NCT05910554 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Metformin
Description: Patients randomized to metformin will be assigned the active arm.
Study NCT05910554 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Cellulose
Description: Patients randomized to cellulose will be assigned the placebo arm.
Study NCT06062472 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: Probiotics
Description: Lactobacillus paracasei PS23 will be used in this study
Study NCT06062472 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: heat-treated of Lactobacillus paracasei HT-PS23
Description: heat-treated probiotic capsule contain 10 billion of Lactobacillus paracasei, 2 caps daily use
Study NCT06062472 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: The placebo capsule contains microcrystalline cellulose, 2 caps daily use
Study NCT05063136 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Capecitabine+endocrine therapy
Description: Capecitabine (500mg, tid) (for 1 year)+ standard endocrine therapy (at least 5 years)
Study NCT05063136 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo+endocrine therapy
Description: Placebo (tid) (for 1 year)+ standard endocrine therapy (at least 5 years)
Study NCT05817344 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Written Exposure Therapy - Integrated
Description: A brief exposure-based psychotherapy for posttraumatic stress disorder integrated with harm reduction strategies for opioid use disorder
Study NCT05668923 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Speech sound stimulation
Description: Behavioral-, electrophysiological-, and magnetic resonance imaging-based speech sound testing
Study NCT06132204 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: HRS-7535 Tablets
Description: HRS-7535 Tablets
Study NCT06369545 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: EXERCISE
Description: All participants included in this group will receive Exercises
Study NCT06369545 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: EXERCISE
Description: All participants included in this group will receive Exercises
Study NCT06369545 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: TENS
Description: All participants included in this group will receive TENS
Study NCT06369545 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: ESWT
Description: All participants included in this group will receive ESWT
Study NCT05356130 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Written Educational Material on BLT
Description: Participants in both Arms 2 and 3 will receive written information about how to obtain the greatest BLT benefit, including recommended day/time usage, session duration, eye distance from light box, the length of time to continue using, and the small risk of emergent mania or BD and how to recognize this. Written best practices for ideal BLT will be provided in both Arms 2 and 3 via secure EHR message, email, and/or USPS. PDFs of best practices for BLT will also be available for download on our study website.
Study NCT05356130 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Enhanced BLT Encouragement and Adherence Promotion
Description: BLT phone coaches will follow a four-step approach in engaging with Arm 3 participants: (a) provide encouragement to consider using BLT; (b) provide guidance regarding light box purchase and assist with obtaining compensation for purchase; (c) educate participants about ideal BLT use to obtain maximum benefit; and (d) provide ongoing brief telephonic adherence promotion and motivational interviewing (MI) where warranted to maximize persistent and appropriate BLT use.
Study NCT04863547 — intervention group
Intervention type: OTHER
Intervention: Data collection
Description: Data collection
Study NCT05189691 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: walking exercise
Description: Initially starting with 10-15 minutes of physical activity, it will continue until it reaches a duration of 30 or 60 minutes, 3 times a week. The goal is to exceed the previous number of steps each time. If they feel fatigue or palpitations during the day, they can do their exercises the next day. If there are complaints of shortness of breath/shortness of breath, chest pain, palpitation during walking, he should take a break from walking and rest. A pedometer will be used to ensure regular follow-up and control, and the number of steps will be marked on the walking tracking chart. They will be told how to keep a record after each exercise. A weekly phone call will be made to motivate the patient and the researcher will be informed that they can call.
Study NCT06240754 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Enasidenib
Description: Provided by BMS.
Study NCT05521178 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Electrocardiogram
Description: ECG to monitor electrical activities of the heart on each visit
Study NCT05521178 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Echocardiogram
Description: Echocardiogram at baseline and 6 months
Study NCT05521178 — intervention group
Intervention type: DIAGNOSTIC_TEST
Intervention: Cardiac magnetic resonance imaging
Description: Cardiac MRI at baseline and 6 months